The Motley Fool

Key Data Points

Primary metrics and data points about Keryx Biopharmaceuticals.
Current Price: $9.82
Prev Close: $9.68
Open: $9.67
Bid: $9.83
Ask: $9.84
Day's Range: $9.51 - $9.85
52wk Range: $8.84 - $18.48
Volume: 732,768
Avg Vol 1,404,578
Market Cap: $1B
P/E (ttm): -7.12
EPS (ttm): ($1.36)
Div & Yield: $0.00 (0.0%)

Business Summary

Industry, sector and description for Keryx Biopharmaceuticals.

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

KERX vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Keryx Biopharmaceuticals.
CAPS Rating 2 out of 5
392 Outperform
67 Underperform
CAPS All Stars
60 Outperform
19 Underperform

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Ron Bentsur, CEO

0% Approve

Based on 0 Ratings

Powered by

More Details about Keryx Biopharmaceuticals

Primary metrics and data points about Keryx Biopharmaceuticals.